药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Insulin detemir
Troxerutin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Troxerutin.
Insulin detemir
Diphenadione
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Diphenadione.
Insulin detemir
Clorindione
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Clorindione.
Insulin detemir
Fluindione
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Fluindione.
Insulin detemir
Ethyl biscoumacetate
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Ethyl biscoumacetate.
Insulin detemir
4-hydroxycoumarin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with 4-hydroxycoumarin.
Insulin detemir
Edetate calcium disodium anhydrous
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Edetate calcium disodium anhydrous.
Insulin detemir
Tocopherylquinone
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Tocopherylquinone.
Insulin detemir
(S)-Warfarin
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with (S)-Warfarin.
Insulin detemir
Saruplase
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Saruplase.
Insulin detemir
Melagatran
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Melagatran.
Insulin detemir
Tioclomarol
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Tioclomarol.
Insulin detemir
Brinase
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Brinase.
Insulin detemir
Protein S human
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Protein S human.
Insulin detemir
Gabexate
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Gabexate.
Insulin detemir
Nafamostat
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Nafamostat.
Insulin detemir
Darexaban
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Darexaban.
Insulin detemir
Letaxaban
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Letaxaban.
Insulin detemir
Antithrombin III human
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Antithrombin III human.
Insulin detemir
Protein C
The risk or severity of hemorrhage can be increased when Levomilnacipran is combined with Protein C.